Subscribe to Newsletter

Bioprocessing - Upstream & Downstream

Manufacture Bioprocessing - Upstream & Downstream

Welcome to the Microbe Factory

| Axel Erler

How can smaller biopharma companies overcome the scale up and production complexities for microbial biomanufacturing?

Manufacture Bioprocessing - Upstream & Downstream

uBioprocess

| Angus Stewart

A microfluidic bioprocessing company has set up shop in central Scotland. We spoke to their CEO for an inside view.

Business & Regulation Profession

Thursday is the Deadline

Nominations and voting for the Power List, Company of the Year Awards, and Innovation Awards ends on Thursday 17 March

Manufacture Advanced Medicine

SaudiVax: Regionalizing and Democratizing Cell & Gene Therapy

| Sponsored by MilliporeSigma

How SaudiVax is partnering to help patients in the Middle East and Africa to access advanced medicine.

Manufacture Supply Chain

Mapping out Material Resilience for Biopharmaceutical Supply Chains

| Sponsored by Thermo Fisher Scientific

A short guide to strengthening raw materials supply chains in the biopharma industry, featuring Luis Bianchi Pintos from Thermo Fisher Scientific.

Business & Regulation Advanced Medicine

Gearing Up for the 2022 Power List and More

2022 is well underway, and with it comes The Medicine Maker Company of the Year Awards. Our old faithful Power List is back too.

Business & Regulation Business Practice

Inside the PenCycle Recycling Scheme

Novo Nordisk explains how its pilot scheme in the UK is helping to recycle injector pens.

Manufacture Ingredients

Don't Get a Raw Deal

| Hunter Malanson

While you’re busy scaling up your bioprocesses, don’t forget about the secure supply of all critical raw materials

Manufacture Biosimilars

Driving Down Biosimilar COGS

| Amanda Turner, Khaled Mriziq

To keep biosimilars costs as low as possible, take a good look at your purification and characterization processes.

Manufacture Advanced Medicine

Can Cell Therapies Take on Solid Tumors?

| Stephanie Vine

Experts explain how cell therapies can tackle tumors in our 2021 supplement on cell and gene therapies.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register